Citigroup’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Citigroup’s Portfolio IMNP Stock Details IMNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4	Closed	–	–	8000
2015 Q2	$0	Sell	4 -9	-69%	-$355	﹤0.01%	7924
2015 Q1	$0	Sell	13 -4	-24%	-$150	﹤0.01%	7592
2014 Q4	$1K	Buy	+17	New	+$914	﹤0.01%	7032

Other funds holding IMNP

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

IFS

Ifrah Financial Services Little Rock, Arkansas $409M AUM 28.15% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Citigroup's IMNP Position: Q3 2015 in Review

Citigroup sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2015, closing a stake of 4 shares.

Citigroup first reported a position in IMNP in Q4 2014 and held it in 3 quarters. The position peaked at $1K in Q4 2014. 15 funds tracked by Wall St. Rank hold IMNP as of Q3 2015.

Citigroup reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2015 after selling out during the quarter.
Citigroup sold 4 Immune Pharmaceuticals Inc. shares in Q3 2015.
Citigroup first reported a position in Immune Pharmaceuticals Inc. in Q4 2014 and held it in 3 quarters.
Citigroup's Immune Pharmaceuticals Inc. position peaked at $1K in Q4 2014.
15 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2015.

Based on Citigroup's 13F filing for Q3 2015, filed 13 Nov 2015.